SpringerLink
Log in

Use of blood urea nitrogen, creatinine, interleukin-6, granulocyte–macrophage colony stimulating factor in combination to predict the severity and outcome of abdominal sepsis in rats

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Objectives

Accurate and timely diagnosis and prognosis of sepsis remain challenging. A combination of markers, as opposed to single ones, may improve the prognosis, and therefore survival. This study compared the effectiveness of routinely used biomarkers of sepsis alone and in combination for the prediction of outcome in rats with abdominal sepsis.

Methods

Rats were subjected to sepsis induced by cecal ligation and puncture (CLP). Seventeen biomarkers were detected 12 h after the CLP. Correlation between the biomarkers and outcome of rats was analyzed; the correlated biomarkers were analyzed by logistic regression analysis and the area under the receiver operating characteristic (ROC) curve was computed to compare their performance in the prognosis of sepsis.

Results

A total of 49 rats were eligible for analysis. Body temperature (T), blood urea nitrogen (BUN), creatinine (Cr), alanine aminotransferase (ALT), creatine kinase (CK), interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) levels after the CLP were negatively correlated with the survival outcome, while platelet count (PLT), high-mobility group box protein 1 (HMGB1) and granulocyte–macrophage colony stimulating factor (GM-CCF) were positively correlated with the survival outcome (P < 0.05). Levels of BUN, Cr, IL-6, and GM-CSF after the CLP were independent predictors of outcome according to conditional logistic regression. The sensitivity and specificity of the four selected biomarkers in combination for predicting sepsis outcome were better than single ones (P < 0.05).

Conclusion

A combination of different biomarkers improves the diagnostic accuracy and is more effective in the prognosis of sepsis in rats. Use of BUN, Cr, IL-6, GM-CSF in combination to predict the severity and outcome in rats with abdominal sepsis exhibited acceptable diagnostic characteristics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Alberta C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, Moreno R, et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med. 2003;168:77–84.

    Article  Google Scholar 

  2. Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ. 2007;335:879–83.

    Article  PubMed  CAS  Google Scholar 

  3. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.

    Article  PubMed  Google Scholar 

  4. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–77.

    Article  PubMed  CAS  Google Scholar 

  5. Meisner M. Biomarkers of sepsis: clinically useful? Curr Opin Crit Care. 2005;11:473–80.

    Article  PubMed  Google Scholar 

  6. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250–6.

    Article  PubMed  Google Scholar 

  7. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010;14:R15.

    Article  PubMed  Google Scholar 

  8. Bagshaw SM, George C, Dinu I, Bellomo R. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2008;23:1203–10.

    Article  PubMed  Google Scholar 

  9. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int. 2008;73:538–46.

    Article  PubMed  CAS  Google Scholar 

  10. Sakr Y, Vincent JL, Schuerholz T, Filipescu D, Romain A, Hjelmqvist H, et al. Early-versus late-onset shock in European intensive care units. Shock. 2007;28:636–43.

    PubMed  CAS  Google Scholar 

  11. Lin SM, Frevert CW, Kajikawa O, Wurfel MM, Ballman K, Mongovin S, et al. Differential regulation of membrane CD14 expression and endotoxin-tolerance in alveolar macrophages. Am J Respir Cell Mol Biol. 2004;31:162–70.

    Article  PubMed  CAS  Google Scholar 

  12. Holly MK, Dear JW, Hu X, Schechter AN, Gladwin MT, Hewitt SM, et al. Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int. 2006;70:496–506.

    PubMed  CAS  Google Scholar 

  13. Heresi GA. Acute renal failure and sepsis. N Engl J Med 2004; 351:2347-9; author reply 2347-9.

  14. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138–50.

    Article  PubMed  CAS  Google Scholar 

  15. Patel RT, Deen KI, Youngs D, Warwick J, Keighley MR. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg. 1994;81:1306–8.

    Article  PubMed  CAS  Google Scholar 

  16. Panacek EA, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab,)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med. 2004;32:2173–82.

    PubMed  CAS  Google Scholar 

  17. Gogos CA, Skoutelis A, Lekkou A, Drosou E, Starakis I, Marangos MN, et al. Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother. 2004;48:2793–8.

    Article  PubMed  CAS  Google Scholar 

  18. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamua M. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine. 2005;29:169–75.

    Article  PubMed  CAS  Google Scholar 

  19. Yoon DY, Chu J, Chandler C, Hiyama S, Thompson JE, Hines OJ. Human cytokine levels in nonperforated versus perforated appendicitis: molecular serum markers for extent of disease? Am Surg. 2002;68:1033–7.

    PubMed  Google Scholar 

  20. Remick DG, Bolgos G, Copeland S, Siddiqui J. Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun. 2005;73:2751–7.

    Article  PubMed  CAS  Google Scholar 

  21. Hamilton JA, Anderson GP. GM-CSF Biology. Growth Factors. 2004;22:225–31.

    Article  PubMed  CAS  Google Scholar 

  22. Presneill JJ, Waring PM, Layton JE, Maher DW, Cebon J, Harley NS, et al. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality. Crit Care Med. 2000;28:2344–54.

    Article  PubMed  CAS  Google Scholar 

  23. Perry SE, Mostafa SM, Wenstone R, McLaughlin PJ. Low plasma granulocyte-macrophage colony stimulating factor is an indicator of poor prognosis in sepsis. Intensive Care Med. 2002;28:981–4.

    Article  PubMed  Google Scholar 

  24. Nierhaus A, Montag B, Timmler N, Frings DP, Gutensohn K, Jung R, et al. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med. 2003;29:646–51.

    PubMed  Google Scholar 

  25. Kylanpaa ML, Mentula P, Kemppainen E, Puolakkainen P, Aittomaki S, Silvennoinen O, et al. Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro. Pancreas. 2005;31:23–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Weixin Hu for his kind assistance in statistical analysis. This research was supported by National Natural Science Foundation of China (81071594).

Author information

Authors and Affiliations

  1. Laboratory of Shock, Department of Pathophysiology, **angya School of Medicine, Central South University, 110 **angya Road, Changsha, 410008, Hunan, People’s Republic of China

    Min Gao, Lingli Zhang, Ying Liu, Nian Wang, Kangkai Wang, Danmin Ou, Meidong Liu, Guangwen Chen, Ke Liu & **anzhong **ao

  2. Department of Emergency and Critical Care Medicine, Third **angya Hospital of Central South University, Changsha, 410008, Hunan, People’s Republic of China

    Mingshi Yang

Authors
  1. Min Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lingli Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ying Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mingshi Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nian Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kangkai Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Danmin Ou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Meidong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Guangwen Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ke Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. **anzhong **ao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Ying Liu or **anzhong **ao.

Additional information

Responsible Editor: Artur Bauhofer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gao, M., Zhang, L., Liu, Y. et al. Use of blood urea nitrogen, creatinine, interleukin-6, granulocyte–macrophage colony stimulating factor in combination to predict the severity and outcome of abdominal sepsis in rats. Inflamm. Res. 61, 889–897 (2012). https://doi.org/10.1007/s00011-012-0481-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-012-0481-3

Keywords

Search

Navigation